Top growth stocks to watch in 2025

What are growth stocks?

Growth stocks are companies expected to increase their earnings and revenue faster than the market average. Instead of paying high dividends, they usually reinvest profits into expanding operations, launching new products or entering new markets.

Common traits include:

• Strong revenue growth year-on-year
• Competitive advantages, such as unique technology or dominant market position
• High price-to-earnings (P/E) ratios compared to peers, reflecting investor confidence in future potential

Growth stocks can be found in various sectors - from tech start-ups to established companies entering new high-growth industries.

Why trade and invest in growth stocks in Singapore?

Singapore’s economy is a hub for finance, technology, logistics and consumer industries. The SGX lists both homegrown growth companies and multinational firms with strong expansion plans in Asia.

Trading growth stocks in Singapore offers:

• Regional exposure: Access to fast-growing ASEAN and Asia-Pacific markets
• Sector diversity: From REIT-linked growth plays to cutting-edge fintech and biotech firms
• Liquidity and regulation: SGX-listed stocks benefit from strong market oversight and relatively high trading volumes

With IG Singapore, you can also access international growth stocks alongside local ones, widening your opportunity set.

Risks of trading and investing in growth stocks

While growth stocks can outperform in bull markets, they carry higher volatility and risk.

Key risks include:

• Valuation risk: High P/E ratios can make prices vulnerable to sharp drops if earnings disappoint
• Market cycles: Growth stocks often underperform during economic slowdowns
• Company-specific risk: Expansion plans may fail, leading to slower revenue growth or losses

Mitigating risk involves diversification, using stop-loss orders, and keeping position sizes manageable.

Top 5 growth stocks to watch

1. DBS Group Holdings (SGX: D05)
 

Sector: Banking and financial Services 
Market cap: S$142 billion 

Financial highlights: DBS Group Q2 2025 profit before tax rose 5% year-on-year (YoY) to S$3.39 billion, while net profit exceeded analyst predictions to increase by 1% YoY to S$2.82 billion. For the first half of 2025, both total income and profit before tax also reached new highs. 

Cash position: DBS maintained a strong cash position with a Common Equity Tier-1 (CET1) ratio of 15.8% as of Q2 2025. This is above regulatory requirements of 100%. The bank's total assets exceeded S$700 billion, reflecting continued growth in its loan portfolio across corporate and consumer segments. Return on equity remained healthy at approximately 16% for the quarter.

Share price performance: DBS shares have gained as much as 18% in 2025, outperforming the broader Straits Times Index. In August 2025, the stock traded at a price-to-earnings (P/E) ratio of 12.9 times (against a five-year average of 10.24 times) and price-to-book (P/B) ratio of 1.3 times (against a five-year average of 1.47 times).

Analyst takes: UOB analysts maintained a ‘hold’ rating on DBS shares with a share price target of S$52.80, citing that DBS’ FY2025 net profit is ‘expected to be lower’ than FY2024 levels. Meanwhile, OCBC, RHB, and Maybank analysts raised their price targets on the DBS stock while keeping ‘buy’ ratings unchanged. 

2. Microsoft Corporation (NASDAQ: MSFT)

Sector: Cloud Computing and software 
Market cap: US$3.75 trillion (S$4.82 trillion)

Latest earnings: Microsoft Q4 2025 net profit rose by 24% YoY, with diluted earnings per share (EPS) growing by the same amount. The tech giant’s outperformance was mainly driven by Azure cloud services, which saw a 34% revenue increase from the same period 12 months prior.

Cash position: Microsoft maintained over US$94.57 billion in cash, cash equivalents, and short-term investments as of 30 June 2025. This is up from the US$75.54 billion recorded 12 months prior. The company also generated a free cash flow of US$25.6 billion during the quarter, up by 10% YoY.

Share price performance: Microsoft shares have gained as much as 33% in 2025, benefiting from strong AI adoption and cloud computing demand. The company joined chipmaker Nvidia in the exclusive US$4 trillion market cap club. The stock has a five-year average P/E ratio of 35.3 times, in line with other big tech firms.

Business outlook: Microsoft is targeting a 28% to 30% revenue growth for Azure cloud services in fiscal 2026. The company's planned AI initiatives, including Copilot integration across Office 365 and Windows, are expected to drive higher subscription revenues. Capital expenditure is also expected to increase to support AI infrastructure expansion globally.

3. NVIDIA Corporation (NASDAQ: NVDA)

Sector: Semiconductors and AI computing 
Market cap: US$4.44 trillion (S$5.71 trillion)

Latest earnings: NVIDIA reported Q1 2026 revenue of $44.1 billion, up 12% from the previous quarter and up 69% from a year ago. Net profit gained by 26% YoY, with diluted EPS up by a similar amount. The company's data center revenue continued to dominate, accounting for approximately 87% of total revenue as AI demand remained robust across enterprise and cloud customers.

Cash position: NVIDIA ended 27 April 2025 with US$15.23 billion in cash and cash equivalents. This is up from the US$7.59 billion of cash and cash equivalents recorded exactly a year prior. Free cash flow grew to over US$26 billion at the end of Q1, up by 68% from US$15.52 billion the previous quarter, and up by 75% from US$14.94 billion a year prior. 

Share price performance: After tumbling in April on fears around trade negotiations, the stock has come roaring back, nearly doubling and becoming the first stock to cross the US$4 trillion market cap threshold. NVIDIA shares have gained as much as 34%% in 2025, outperforming broader market indices. The stock has a five-year average P/E ratio of 73.3 times.

Business outlook: NVIDIA expects continued strong demand for its Hopper and upcoming Blackwell architecture chips. The company anticipates Q2 2026 revenue of approximately US$45 billion, to be driven by enterprise AI adoption and cloud service provider investments. Management is also expecting for unadjusted and adjusted gross margins to be around 71.8% and 72.0%, higher than Q1’s 60.5%.

4. Palantir Technologies (NASDAQ: PLTR)

Sector: Data analytics and AI software 
Market cap: US$373.77 billion (S$480.29 billion)

Latest earnings: Palantir saw Q2 2025 revenue grow 48% YoY to cross US$1 billion for the first time. Net profit surged by 142% YoY to US$328.57 million. During the quarter, the company closed a record-setting US$2.27 billion of total contract value, up by 140% YoY. Finally, customer count grew by 43% from a year prior.

Cash position: Palantir ended the quarter with an adjusted free cash flow of US$568.77 million, up from US$148.66 million a year prior. This equated to an adjusted free cash flow margin of 57% for Q2 2025, up from 22% in Q2 2024. The company also recorded US$951 million in cash, cash equivalents, and restricted cash for the six months ending on 30 June 2025, up by 79% from the six months prior. 

Share price performance: Palantir shares have soared as much as 152% in 2025, making it one of the best-performing stocks in the S&P 500 year-to-date. The stock traded at highly elevated valuations as of August 2025, with a price-to-sales ratio of approximately 115.39 times. The stock’s five-year average P/E ratio also stood at an exceptional 97.1 times.

Business outlook: Management is expecting for Q3 2025’s revenue to grow by around 50% YoY, driven by expanding government contracts and accelerating commercial customer adoption. In view of that, it also raised its full-year 2025 revenue guidance to a YoY growth of around 45%. 

5. Raffles Medical Group (SGX: BSL)

Sector: Healthcare Services 
Market cap: S$1.9 billion

Latest earnings: Raffles Medical reported steady growth in H1 2025 with revenue increasing 3.5% YoY to S$378.4 million. Net profit grew 4.8% YoY to S$32.1 million, supported particularly by the Hospital Services division, which saw profits surging by 24.3% YoY.

Cash position: The group maintained a balance sheet with cash and cash equivalents of S$334.2 million as of 30 June 2025, up from the S$316.3 million that it recorded a year ago. Loans and borrowings totalled S$51.2 million in 1H 2025, compared to S$56 million six months earlier. 

Share price performance: Raffles Medical Group shares have rallied as much as 27.4% in 2025. The stock traded at a P/E ratio of around 29.5 times in August 2025, above its five-year average of 24.9 times. Meanwhile, it had a P/B value of 1.83 times, which is slightly below its historical average of 2.07 times. 

Business outlook: The board of directors are positive that Raffles Medical Group will remain profitable in FY2025, based on current market conditions and barring any unforeseen circumstances. The board expects continued business growth in view of Singapore's aging population and increasing healthcare spending.

How to trade and invest in growth stocks with IG Singapore

CFD share trading
 

1. Create a live or demo account
2. Find an opportunity among one of our 10,000+ stocks with our  stock screener
3. Click ‘buy’ to go long or ‘sell’ to short
4. Set your position size
5. Take steps to manage your risk
6. Open and monitor your position

Investing
 

1. Open an account via IG Markets Singapore app
2. Search for meme stocks on the app
3. Choose the shares you want to buy
4. Determine how many shares you want to purchase
5. Place your order
6. Monitor your investment and collect any dividends

FAQs about growth stocks